Publication
Title
Of worms, mice and man : an overview of experimental and clinical helminth-based therapy for inflammatory bowel disease
Author
Abstract
The incidence of inflammatory and autoimmune disorders is highest in well-developed countries which is directly related to their higher hygienic standards: it is suggested that the lack of exposure to helminths contributes to the susceptibility for immune-related diseases. Epidemiological, experimental and clinical data support the idea that helminths provide protection against immune-mediated diseases such as inflammatory bowel disease (IBD). The most likely mechanism for the suppression of immune responses by helminths is the release of helminth-derived immunomodulatory molecules. This article reviews the experimental and clinical studies investigating the therapeutic potential of helminth-based therapy in IBD and also focuses on the current knowledge of its immunomodulatory mechanisms of action highlighting innate as well as adaptive immune mechanisms. Identifying the mechanisms by which these helminths and helminth-derived molecules modulate the immune system will help in creating novel drugs for the treatment of IBD and other disorders that result from an overactive immune response. (C) 2014 Elsevier Inc. All rights reserved.
Language
English
Source (journal)
Pharmacology and therapeutics. - Oxford
Publication
Oxford : 2014
ISSN
0163-7258
DOI
10.1016/J.PHARMTHERA.2014.02.011
Volume/pages
143 :2 (2014) , p. 153-167
ISI
000339221500003
Full text (Publisher's DOI)
Full text (publisher's version - intranet only)
UAntwerpen
Faculty/Department
Research group
Project info
Role of dendritic cells in Th1/Th17-mediated immune diseases.
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identifier
Creation 08.09.2014
Last edited 04.03.2024
To cite this reference